Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Acyclovir capsule preparation and preparation method thereof

A preparation and capsule technology, applied in the field of medicine, can solve the problems of large amount of sustained-release materials, poor release consistency, and reduce production costs, and achieve the effect of zero-order drug release, low production costs, and fewer types of excipients

Inactive Publication Date: 2013-12-25
NANJING ZHENGLIANG MEDICAL TECH
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The above-mentioned patented process adopts ordinary wet granulation, so the amount of sustained-release materials is relatively large; the release consistency is poor, which may easily cause sudden or uneven drug release
[0004] In summary, there are many types of technical auxiliary materials for preparing acyclovir capsules, and the consumption is large, which is not conducive to reducing production costs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Acyclovir capsule preparation and preparation method thereof
  • Acyclovir capsule preparation and preparation method thereof
  • Acyclovir capsule preparation and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019]

[0020] Preparation Process:

[0021] Prescription amount Weigh acyclovir, ethyl cellulose and high-substituted hydroxypropyl cellulose, add to ethanol, stir to dissolve, add to liquid paraffin containing 0.5% (v / v) Span 80 under stirring conditions , gradually raised the temperature to 40°C, kept stirring for 6 hours, raised the temperature to 70°C, stirred for 1 hour, and filtered under reduced pressure to obtain acyclovir sustained-release pellets, which were filled into capsule shells.

Embodiment 2

[0023]

[0024] Preparation Process:

[0025] Prescription quantity Weigh acyclovir, ethyl cellulose and high-substituted hydroxypropyl cellulose, add it to ethanol, stir to dissolve, and add it to liquid paraffin containing 2% (v / v) Span 80 under stirring conditions , gradually raised the temperature to 40°C, kept stirring for 6 hours, raised the temperature to 70°C, stirred for 1 hour, and filtered under reduced pressure to obtain acyclovir sustained-release pellets, which were filled into capsule shells.

Embodiment 3

[0027]

[0028]

[0029] Preparation Process:

[0030] Prescription amount Weigh acyclovir, ethyl cellulose and high-substituted hydroxypropyl cellulose, add to ethanol, stir to dissolve, add to liquid paraffin containing 0.5% (v / v) Span 80 under stirring conditions , gradually raised the temperature to 40°C, kept stirring for 6 hours, raised the temperature to 70°C, stirred for 1 hour, and filtered under reduced pressure to obtain acyclovir sustained-release pellets, which were filled into capsule shells.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an acyclovir capsule preparation. The acyclovir capsule preparation comprises a capsule shell and content, wherein the content is an acyclovir sustained-release pellet, and the acyclovir sustained-release pellet is prepared by the following steps of dissolving acyclovir, ethyl cellulose and high-substituted hydroxypropyl cellulose in ethyl alcohol, adding into liquid paraffin containing surfactant while stirring, gradually heating up to 38-42 DEG C, keeping warm and stirring for 4-8 hours, heating up to 68-72 DEG C, stirring for 0.5-2 hours, and filtering under diminished pressure, thereby obtaining the acyclovir sustained-release pellet. According to the acyclovir capsule preparation, the dosage of the sustained-release material is greatly reduced, and the phenomenon of initial burst release of the medicine is eliminated.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to an antiviral drug preparation, in particular to an acyclovir capsule preparation and a preparation method thereof. Background technique [0002] Acyclovir is a synthetic purine nucleoside analogue. It is mainly used for various infections caused by herpes simplex virus, and can be used for initial or recurrent skin, mucous membrane, external genital infection and HSV infection in immunocompromised persons. It is the drug of choice for the treatment of HSV encephalitis, and it is superior to adenosine vidarabine in reducing morbidity and mortality. It can also be used for herpes zoster, Epstein-Barr virus, and immunodeficiency complicated by chickenpox and other infections. For topical use on the skin only, acyclovir has less skin absorption. [0003] CN 101502521B discloses a group of acyclovir sustained-release preparation compositions and a preparation method th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/48A61K31/522A61K47/38A61P31/22
Inventor 不公告发明人
Owner NANJING ZHENGLIANG MEDICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products